Cargando…
Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis
Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused significant health and economic havoc around the globe. One of the early agents targeted for repurposing to treat and prevent COVID-19 was hydroxychloroquine (HCQ). In this systemati...
Autores principales: | Hong, Thomas S., Gonzalez, Jimmy, Nahass, Ronald G., Brunetti, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711623/ https://www.ncbi.nlm.nih.gov/pubmed/33167571 http://dx.doi.org/10.3390/pharmacy8040208 |
Ejemplares similares
-
Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020) -
Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020) -
The Association of Serotonin Toxicity with Combination Linezolid–Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis
por: SanFilippo, Savanna, et al.
Publicado: (2023) -
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
por: Brunetti, Luigi, et al.
Publicado: (2020) -
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
por: Ayerbe, Luis, et al.
Publicado: (2020)